Outlook Therapeutics (OTLK) Prepaid Assets (2015 - 2026)
Outlook Therapeutics (OTLK) reported Prepaid Assets of $7.1 million for Q1 2026, up 6.71% year-over-year from $6.6 million in Q1 2025, and up 44.26% quarter-over-quarter from $4.9 million in Q4 2025.
Outlook Therapeutics (OTLK) Prepaid Assets (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 12 years of Prepaid Assets data on file, last reported at $7.1 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $7.1 million, up 6.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (up 6.71% YoY), and the FY2025 annual result was $4.5 million, down 64.15% from the prior year.
- Prepaid Assets grew to $7.1 million in Q1 2026 per OTLK's latest filing, from $4.9 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $13.6 million in Q2 2024 and troughed at $4.5 million in Q3 2025.
- A 5-year average of $8.7 million and a median of $9.3 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 64.6% in 2024, then plunged 64.15% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $9.3 million in 2022, then advanced by 7.47% to $10.0 million in 2023, then sank by 31.67% to $6.9 million in 2024, then decreased by 28.28% to $4.9 million in 2025, then surged by 44.26% to $7.1 million in 2026.
- Business Quant data shows OTLK's Prepaid Assets at $7.1 million in Q1 2026, $4.9 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.09 Mn |
| Dec 31, 2025 | 4.92 Mn |
| Sep 30, 2025 | 4.48 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.65 Mn |
| Dec 31, 2024 | 6.86 Mn |
| Sep 30, 2024 | 12.49 Mn |
| Jun 30, 2024 | 13.59 Mn |
| Mar 31, 2024 | 10.56 Mn |
| Dec 31, 2023 | 10.03 Mn |
| Sep 30, 2023 | 7.59 Mn |
| Jun 30, 2023 | 9.31 Mn |
| Mar 31, 2023 | 9.42 Mn |
| Dec 31, 2022 | 9.34 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 11.49 Mn |
| Mar 31, 2022 | 8.12 Mn |
| Dec 31, 2021 | 7.32 Mn |
| Sep 30, 2021 | 7.03 Mn |
| Jun 30, 2021 | 12.21 Mn |